Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Charatcharoenwitthaya
Phunchai
P
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Lindor
Keith D
KD
D000469:Alkaline Phosphatase / Q000097:blood*; D001650:Bile Duct Neoplasms / Q000175:diagnosis*; D001653:Bile Ducts, Intrahepatic; D014408:Biomarkers, Tumor / Q000097:blood; D001706:Biopsy / Q000379:methods; D018395:CA-19-9 Antigen / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000097:blood; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D018281:Cholangiocarcinoma / Q000175:diagnosis*; D015209:Cholangitis, Sclerosing / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D003093:Colitis, Ulcerative / Q000150:complications; D003952:Diagnostic Imaging; D018450:Disease Progression; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen; D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid; D000469:Alkaline Phosphatase